| Ytd | -4.48% | |
| 1y | 376.67% |
| Open | 5.86 | Prev Close | 5.90 | Low | 5.00 | High | 6.01 | Mkt Cap | 474.88M |
| Vol | 1.68M | Avg Vol | 1.02M | EPS | -1.09 | P/E | N/A | Forward P/E | -3.22 |
| Beta | 0.14 | Short Ratio | 14.48 | Inst. Own | 58.01% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 4.51 | 200-d Avg | 4.75 | 1yr Est | 14.29 |
ZURA News
Tibulizumab is the first and only bispecific antibody targeting both BAFF and IL-17 in clinical deve
HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical stage biotech
Zura Bio (NASDAQ:ZURA) reported quarterly losses of $(0.22) per share which missed the analyst conse
https://www.sec.gov/ix?doc=/Archives/edgar/data/1855644/000110465926047784/tm2612540d1_8k.htm
U.S. stock futures fall around 250 points on Monday. ASTS shares drop 13.5% after satellite placed i
Oppenheimer analyst Justin Kim maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the
Zura Bio (NASDAQ:ZURA) reported quarterly losses of $(0.49) per share which missed the analyst conse
Zura Bio Limited (NASDAQ:ZURA) ("Zura"), a clinical-stage biotechnology company developing n
Zura Bio Limited (NASDAQ:ZURA), a clinical-stage biotechnology company developing novel and differen
Wedbush analyst Martin Fan initiates coverage on Zura Bio (NASDAQ:ZURA) with a Outperform rating
Zura Bio Limited (Nasdaq: ZURA) ("Zura" or the "Company"), a clinical-stage biotechn
Zura Bio Limited (NASDAQ:ZURA) ("Zura"), a clinical-stage biotechnology company developing n
Chardan Capital analyst Daniil Gataulin maintains Zura Bio (NASDAQ:ZURA) with a Buy and maintains
Zura Bio (NASDAQ:ZURA) reported quarterly losses of $(0.21) per share which missed the analyst conse
Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The comp
Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday'
Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announce
https://blog.tipranks.com/these-2-strong-buy-penny-stocks-could-jump-at-least-300-says-piper-sandler
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) gained 109.8% to $1.06 after reporting a rise in
Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead en